Management Bundle Lowers Mortality in Enterococcal Bloodstream Infections
November 15th 2019The introduction of a bundle of interventions, including infectious disease consultation, echocardiography, follow-up blood cultures and targeted antimicrobial treatment was linked to lower mortality in enterococcal bloodstream infection, a new study found.
Cefiderocol Approved by FDA for cUTI
November 15th 2019Cefiderocol has been approved for the treatment of complicated urinary tract infections (cUTI), including kidney infections caused by susceptible gram-negative microorganisms, who have limited or no alternative treatment options. Labeling includes a warning regarding the higher all-cause mortality rate in the CREDIBLE-CR study.
Bimodal Release Oral Ondansetron Shows Promise in Phase 3 Study
November 14th 2019Intravenous treatment of acute gastroenteritis can be costly and uncomfortable. A phase 3 clinical trial showed positive results for a bimodal release oral ondansetron tablet, finding the drug effective in treating nausea and vomiting.